That, of course, was before the 95% success rates for the rMNA vaccines came out. Those statements may have been overstated in ways still they were much higher than expected and that did raise expectations. I do agree with him that it makes people act in a more carefree manner which promotes surges. We now are also paying much more attention to variants that are a constant threat. In the long run, he may very well be right that we may need annual or more often boosters. His arguments might add weight to the idea of asking for a commitment or strongly urging those who get Zyesami treatment to also get a vaccination. Even Trump got the vaccine after having been treated for COVID.
He certainly is right about the need for a very long surveillance period to follow-up on possible problematic effects of the vaccines.
News 
Market Data 
Discover 
